Literature DB >> 16844690

Defining the CD59-C9 binding interaction.

Yuxiang Huang1, Fei Qiao, Ruben Abagyan, Starr Hazard, Stephen Tomlinson.   

Abstract

CD59 is a membrane glycoprotein that regulates formation of the cytolytic membrane attack complex (MAC or C5b-9) on host cell membranes. It functions by binding to C8 (alpha chain) and C9 after their structural rearrangement during MAC assembly. Previous studies indicated that the CD59 binding site in C9 was located within a 25-residue disulfide-bonded loop, and in C8alpha was located within a 51-residue sequence that overlaps the CD59 binding region of C9. By peptide screens and the use of peptides in binding assays, functional assays, and computer modeling and docking studies, we have identified a 6-residue sequence of human C9, spanning residues 365-371, as the primary CD59 recognition domain involved in CD59-mediated regulation of MAC formation. The data also indicate that both C8alpha and C9 bind to a similar or overlapping site on CD59. Furthermore, data from CD59-peptide docking models are consistent with the C9 binding site on CD59 located at a hydrophobic pocket, putatively identified previously by CD59 mutational and modeling studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844690     DOI: 10.1074/jbc.M603690200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.

Authors:  J A Trapani
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

2.  Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.

Authors:  Xiaohu Ge; I-Ning E Wang; Ildiko Toma; Vittorio Sebastiano; Jianwei Liu; Manish J Butte; Renee A Reijo Pera; Phillip C Yang
Journal:  Stem Cells Dev       Date:  2012-06-11       Impact factor: 3.272

Review 3.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31

4.  4-Hydroxy-7-oxo-5-heptenoic Acid Lactone Is a Potent Inducer of the Complement Pathway in Human Retinal Pigmented Epithelial Cells.

Authors:  Mikhail Linetsky; Karina S Bondelid; Sofiya Losovskiy; Vadym Gabyak; Mario J Rullo; Thomas I Stiadle; Vasu Munjapara; Priyali Saxena; Duoming Ma; Yu-Shiuan Cheng; Andrew M Howes; Emeka Udeigwe; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2018-07-09       Impact factor: 3.739

Review 5.  The good and evil of complement activation in HIV-1 infection.

Authors:  Qigui Yu; Richard Yu; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

6.  Structure of human C8 protein provides mechanistic insight into membrane pore formation by complement.

Authors:  Leslie L Lovelace; Christopher L Cooper; James M Sodetz; Lukasz Lebioda
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

Review 7.  Role of complement and complement regulatory proteins in the complications of diabetes.

Authors:  Pamela Ghosh; Rupam Sahoo; Anand Vaidya; Michael Chorev; Jose A Halperin
Journal:  Endocr Rev       Date:  2015-04-10       Impact factor: 19.871

8.  New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.

Authors:  Gloriane Schnabolk; Mee Keong Beon; Stephen Tomlinson; Bärbel Rohrer
Journal:  J Ocul Pharmacol Ther       Date:  2017-03-23       Impact factor: 2.671

9.  Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration.

Authors:  Katayoon B Ebrahimi; Natalia Fijalkowski; Marisol Cano; James T Handa
Journal:  J Pathol       Date:  2013-01-24       Impact factor: 7.996

10.  Characterization and expression analysis of SOLD1, a novel member of the retrotransposon-derived Ly-6 superfamily, in bovine placental villi.

Authors:  Koichi Ushizawa; Toru Takahashi; Misa Hosoe; Keiichiro Kizaki; Kazuyoshi Hashizume
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.